je.st
news
Tag: biogen
's Biotech Weekly: A Biogen Deep Dive, Eisai's Arena Shuffle, And More
2015-04-11 04:58:51| Biotech - Topix.net
Every Friday, SA highlights some of the week's insightful pieces of opinion and analysis as well as noteworthy Breaking News stories. What should Seeking Alpha be tracking in the biotech world? Leave a comment to let us know.
Biogen Idec shortens its name to Biogen
2015-03-23 15:31:48| Biotech - Topix.net
It said the moves reflects both its evolution and focus on bringing forth new therapies in areas of high unmet need while honoring its legacy as a pioneer in the biotechnology industry. The company was created 12 years ago through the merger of Biogen with IDEC Pharmaceuticals and has since focused on three core areas, including neurology, immunology and hematology.
KB Home, Biogen, Macerich, Tiffany and AK Steel are big market movers
2015-03-20 22:16:38| Steel - Topix.net
Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market: Fellow mall operator Simon Property boosted its hostile bid for the company, saying it was making its best and final offer. The steel company forecast a first-quarter loss because of an increase in imports and lower-than-expected shipments and prices.
Biogen releases Alzheimer's drug data
2015-03-20 14:23:33| Biotech - Topix.net
Biogen Idec released much anticipated results from a study of a potential Alzheimer's disease treatment on Friday, showing that it slowed cognitive decline in some patients. In December, the biotechnology company said the developing drug aducanumab reduced a type of plaque in the brain believed to play a key role in the disease and slowed clinical impairment in patients with a mild form of the disease.
Tags: data
releases
drug
alzheimers
Biogen releases Alzheimer's early trial data showing significant improvement
2015-03-20 14:23:32| Biotech - Topix.net
Biogen Idec's shares soared 11 percent last week to near the company's all-time high in March of the year. The state's most valuable company as measured by market cap, Biogen Idec , will likely rise to new all-time highs Friday on the strength of promising early-stage trial data of its Alzheimer's drug.
Tags: data
showing
early
significant
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »